Fundraising FoxRxAnte
Portland, US · Delaware corporation · 3 known investors
Find your way into RxAnte
Sign up to see every warm intro you have to RxAnte
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RxAnte team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RxAnte provides tech-enabled, value-based pharmacy care management, including analytics and quality-improvement tools plus high-touch pharmacy services, for health plans, providers, and pharmacies. Its programs aim to improve medication use and health outcomes for at-risk members while lowering healthcare costs.
Founders & leadership
LJ
Lisa JurinkaSVP, General CounselLisa Jurinka has held in-house counsel positions at both public and private companies, with expertise in corporate governance, M&A, regulatory compliance, and licensing in digital health and other regulated sectors. She has built and led legal departments across multiple growth stages, from Series A through IPO.
NC
Niteesh ChoudhrySVP, Chief Medical and Science OfficerNiteesh Choudhry is an internist and health services researcher whose work spans behavioral science and data science, with focus on medication adherence and prescribing practices. He has collaborated with health insurers, delivery systems, and technology developers to design and evaluate interventions aimed at improving healthcare quality.
PB
Patrick BakerSVP, General Manager at Mosaic Pharmacy Service
JF
Jessica FrankSVP, Client SuccessShe has held leadership roles in healthcare focused on value-based care, population health management, and medication therapy programs across Medicare, Medicaid, and commercial plans, with particular expertise in Medicare Star Ratings and medication use quality measures.
MK
Mohit KaushalNamed on SEC filing
NS
Nicholas ShapiroNamed on SEC filing
GL
Greg LahensNamed on SEC filing
MW
Marc WisePresident
BB
Brenton BurnsNamed on SEC filing
CD
Corbin DirectorSVP, Chief Financial Officer
Investors · 3
Primus Capital✓ confirmed by RxAnte
How we know: the company's own site · funding news · press coverage · Not right? Tell us
First Trust Capital Partnerslisted by First Trust Capital PartnersWheaton · $5M
How we know: First Trust Capital Partners's portfolio page · Not right? Tell us
Aberdare VenturesreportedSan Francisco · $500K – $15M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$10.9M disclosed across 1 round · 2020
▶$10.9MraisedMay 2022 · 7 investors · Other Health CareRule 506(b)
▶$10.9MraisedMay 2022 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mohit KaushalDirector
- Nicholas ShapiroDirector
- Greg LahensExecutive Officer
- Marc WiseExecutive Officer
- Brenton BurnsDirector
- Joshua BennerExecutive Officer, Director
- Corbin DirectorExecutive Officer
- Eileen CasalExecutive Officer
- Jonathan PhillipsDirector
- Loren LidskyExecutive Officer
- Chronis ManolisDirector
- Offering amount
- $10.9M
- Amount sold
- $10.9M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
RxVantagePlatform connecting healthcare providers with life science experts to access critical information and insights.
Redsail TechnologiesRedSail Technologies provides pharmacy management systems and integrated pharmacy solutions serving health systems and pharmacy operations across the United States. The company delivers software, automation, and clinical programs to optimize medication management and patient care outcomes in healthcare settings.
Guardant HealthGuardant Health develops blood-based testing (liquid biopsy) for cancer detection and monitoring across all stages of the disease. The company serves oncologists, patients, and biopharmaceutical firms with FDA-approved tests for cancer screening, early-stage risk assessment, and treatment selection.
Companies working in the same space as RxAnte.
In the news
Frequently asked questions
- What does RxAnte do?
- RxAnte provides tech-enabled, value-based pharmacy care management, including analytics and quality-improvement tools plus high-touch pharmacy services, for health plans, providers, and pharmacies. Its programs aim to improve medication use and health outcomes for at-risk members while lowering healthcare costs.
- Who founded RxAnte?
- RxAnte was founded by Josh Benner.
- Who are RxAnte's investors?
- RxAnte's investors include Primus Capital, First Trust Capital Partners, Aberdare Ventures.
- How much funding has RxAnte raised?
- RxAnte has disclosed $10.9M raised across 1 round.
- Where is RxAnte headquartered?
- RxAnte is headquartered in Portland, US.